COLACI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.180
EU - Europa 12.235
AS - Asia 6.825
SA - Sud America 976
Continente sconosciuto - Info sul continente non disponibili 302
AF - Africa 182
OC - Oceania 18
Totale 42.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.697
IT - Italia 5.658
GB - Regno Unito 2.949
SG - Singapore 2.076
CN - Cina 1.736
SE - Svezia 802
HK - Hong Kong 801
BR - Brasile 749
VN - Vietnam 618
DE - Germania 550
FR - Francia 482
UA - Ucraina 448
FI - Finlandia 426
BD - Bangladesh 395
TR - Turchia 357
RU - Federazione Russa 315
CA - Canada 226
NL - Olanda 159
IN - India 146
BG - Bulgaria 138
KR - Corea 134
ID - Indonesia 119
MX - Messico 90
AR - Argentina 86
JP - Giappone 67
AE - Emirati Arabi Uniti 63
ZA - Sudafrica 56
IQ - Iraq 53
PL - Polonia 42
EC - Ecuador 35
PK - Pakistan 35
ES - Italia 32
IE - Irlanda 30
BE - Belgio 29
CO - Colombia 27
IL - Israele 27
MY - Malesia 26
MA - Marocco 24
RO - Romania 24
CH - Svizzera 23
VE - Venezuela 23
CL - Cile 22
CR - Costa Rica 21
SA - Arabia Saudita 20
SC - Seychelles 20
JM - Giamaica 19
TN - Tunisia 19
TT - Trinidad e Tobago 19
EG - Egitto 18
IR - Iran 18
AU - Australia 17
PH - Filippine 17
AT - Austria 16
GT - Guatemala 16
BZ - Belize 15
LT - Lituania 15
NP - Nepal 14
UZ - Uzbekistan 14
HN - Honduras 13
KE - Kenya 12
SV - El Salvador 12
PR - Porto Rico 11
TH - Thailandia 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
HU - Ungheria 10
JO - Giordania 10
PY - Paraguay 10
BO - Bolivia 9
NI - Nicaragua 9
PE - Perù 9
GR - Grecia 8
NO - Norvegia 8
TW - Taiwan 8
BY - Bielorussia 7
CW - ???statistics.table.value.countryCode.CW??? 7
EU - Europa 7
GP - Guadalupe 7
KG - Kirghizistan 7
PT - Portogallo 7
DO - Repubblica Dominicana 6
LB - Libano 6
OM - Oman 6
BB - Barbados 5
DK - Danimarca 5
EE - Estonia 5
ET - Etiopia 5
GE - Georgia 5
HR - Croazia 5
KZ - Kazakistan 5
MD - Moldavia 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
CY - Cipro 4
DZ - Algeria 4
ML - Mali 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
Totale 42.371
Salva come PNG Salva come JPEG
Città #
Ashburn 2.387
Southend 2.236
Fairfield 1.826
Santa Clara 1.671
Singapore 1.386
Woodbridge 1.069
Houston 850
San Jose 792
Hong Kong 787
Chicago 756
Chandler 751
Jacksonville 728
Seattle 703
Wilmington 623
Council Bluffs 615
Cambridge 599
Los Angeles 539
Ann Arbor 532
Dearborn 502
Milan 432
Nyköping 425
Rome 399
Hefei 369
Beijing 361
London 343
Salt Lake City 309
Helsinki 306
New York 253
Izmir 221
The Dalles 219
Modena 214
Ho Chi Minh City 182
Tampa 164
Hanoi 162
San Diego 149
Dallas 145
Princeton 144
Sofia 134
Elk Grove Village 131
Seoul 127
Eugene 123
Naples 114
Columbus 112
Lauterbourg 110
Buffalo 106
Florence 103
São Paulo 101
Bologna 99
Palermo 92
Jakarta 82
Bari 79
Catania 79
Turin 79
Boardman 78
Shanghai 78
Sterling 78
Toronto 78
Frankfurt am Main 77
Bremen 73
Phoenix 72
Redwood City 72
Des Moines 69
Moscow 67
Genoa 60
Atlanta 58
Lancaster 57
Detroit 47
Miami 47
Verona 47
Guangzhou 44
Padova 41
Orem 39
Dulles 38
North Bergen 38
Tokyo 37
Mexico City 36
Brooklyn 33
Cagliari 32
Norwalk 31
Da Nang 30
Denver 30
Munich 30
Kunming 27
Pisa 27
Warsaw 27
Falls Church 26
Haiphong 26
San Francisco 25
Amsterdam 24
Johannesburg 24
Montreal 24
Venice 24
Chennai 23
Jersey City 23
Newark 23
Parma 23
Pittsburgh 23
Salerno 23
Delhi 22
Dublin 22
Totale 27.773
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.908
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 997
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 778
Semeiotica dell'articolazione temporo-mandibolare 606
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 514
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 494
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 493
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 464
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 409
Heart involvement and systemic sclerosis 406
Endocrine manifestations of hepatitis C virus infection. 406
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 404
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 398
Thymus alterations and systemic sclerosis 398
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 392
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 392
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 392
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 386
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 386
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 385
Current treatment of hepatitis C-associated rheumatic diseases. 385
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 377
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 370
Scleroderma digital ulcers complicated by infection with fecal pathogens. 366
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 363
Aortic pulse wave velocity measurement in systemic sclerosis patients. 363
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 362
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 357
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 355
Elevated Troponin Serum Levels in Adult Onset Still's Disease 354
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 348
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 346
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 346
L-Arginine in pregnant scleroderma patients 343
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 343
Associations between Systemic Sclerosis and Thyroid Diseases 342
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 340
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 340
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 340
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 338
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 336
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 336
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 335
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 333
Platelet gel in the treatment of severe scleroderma skin ulcers. 332
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 324
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 320
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 313
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 313
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 313
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 312
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 310
[CXCR3 and CXCL10 in autoimmune thyroiditis] 307
Cardiovascular risk and prostanoids in systemic sclerosis 303
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 301
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 299
IP-10 in autoimmune thyroiditis 297
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 296
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 294
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 293
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 293
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 292
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 291
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 290
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 289
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 288
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 285
New targeted molecular therapies for dedifferentiated thyroid cancer 285
The safety of iloprost in systemic sclerosis in a real-life experience 283
Renal Manifestations of Hepatitis C Virus 280
HCV-related rheumatic manifestations and therapeutic strategies 279
Mixed cryoglobulinemia syndrome: where are we going to? 277
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 275
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 271
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 271
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 271
Osteomyelitis complicating scleroderma digital ulcers. 267
Novel Therapies for Thyroid Autoimmune Diseases 267
Treatment of HCV-related mixed cryoglobulinemia 267
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features 265
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 262
RET TKI: potential role in thyroid cancers. 262
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 262
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 261
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 256
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 253
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 252
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 249
CXCL10 in psoriasis 246
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 246
Valore predittivo di uno score capillaroscopico nei pazienti sclerodermici. 245
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 243
Severe alopecia complicating systemic sclerosis 241
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 240
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 239
Trattamento con Rituximab in pazienti con vasculite crioglobulinemica. 235
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 234
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 225
Storia naturale della sclerosi sistemica in Italia. 225
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 225
Totale 36.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.779 0 0 0 0 100 181 140 135 280 223 390 330
2022/20233.426 395 246 182 231 401 421 209 307 426 133 299 176
2023/20243.048 134 196 196 345 503 260 290 308 88 185 236 307
2024/20256.012 290 120 152 487 1.193 891 405 320 624 321 601 608
2025/202611.539 490 303 670 1.711 2.855 742 1.187 460 874 830 746 671
2026/20273.305 339 602 760 1.418 186 0 0 0 0 0 0 0
Totale 42.718